This important study provides solid evidence to support the anti-tumor potential of citalopram, originally an anti-depression drug, in hepatocellular carcinoma (HCC). In addition to their previous ...
编辑丨王多鱼排版丨水成文抗 PD-1 联合仑伐替尼(lenvatinib,一种多靶点受体酪氨酸激酶抑制剂)治疗在多种肿瘤中均显示出临床疗效,但潜在的免疫学机制尚不清楚。2025 年 1 月 30 ...
CD4-positive T cells are a subtype ... have altered cholesterol metabolism, and induce CD8 + T cell senescence to dampen anti-tumor immunity. Regulatory T cells play critical roles in the control ...
CD8 + T cell exhaustion is defined ... can boost anti-tumor immune responses in gliomas. Here the authors report that CD4 + T cells are required for the therapeutic activity of an oHSV ...
The Super Specialty Hospital (SSH) administration here has claimed to have achieved a medical milestone by performing CAR ...
Talimogene laherparepvec (T-VEC) demonstrates efficacy in cutaneous BCC, enhancing resectability and altering immune cell ...
Induces potent and long-lasting immune responses to defined antigens or whole pathogens (particles), mainly through the ...
Brain Tumor Organoids Accurately Model Patient Response to CAR T Cell Therapy Dec. 9, 2024 — Researchers used lab-grown organoids created from tumors of individuals with glioblastoma (GBM ...
22% of CD8+ T-cells are located in stroma areas (outlined in green). Distance of tumor cells from blood vessels ... with DAPI and for FOXP3, CD25 and CD4.
More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.
CD4-cell counts and T-cell activation levels were determined ... and higher LPS levels were associated with greater activation of CD8 + lymphocytes. CD8 + activation also was found to be higher ...